Class II

Drug Recall: Irbesartan Tablets USP, 300 mg, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKARE, Pulaski, TN 38478. NDC 50268-442-15

AvKARE · January 21, 2025

Reason for Recall

Out of Specification for Dissolution

Distribution

Nationwide in the USA

States Affected

NATIONWIDE

Quantity Affected

341 cartons

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0224-2025

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.